Biotech2050

🎯 What does it take to lead a biotech from clinical trials to commercial launch—while staying true to a bold mission? In this powerful conversation, Jeremy Bender, CEO of Day One Biopharmaceuticals, joins Rahul Chaturvedi to share how his team secured FDA approval for a pediatric brain cancer drug and built a culture of performance, purpose, and resilience. 💡 Hear how Jeremy’s journey—from immunology to big pharma to first-time CEO—has shaped Day One’s strategy, values, and pipeline. They cover: 🔬 The challenges of pediatric drug development 🏥 Day One’s approach to scaling with limited resources 🧠 Insights on culture, leadership, and capital efficiency 📊 How AI and biomarkers are reshaping oncology R&D 🧒 Why children shouldn’t be an afterthought in innovation 🎧 Don’t miss this episode of #Biotech2050: https://xmrrwallet.com/cmx.plnkd.in/gk3gFeG4 #BiotechLeadership #PediatricOncology #FDAApproval #Biotech2050 #BiopharmaStrategy #CancerInnovation #OncologyR&D #RareDiseases #BiotechStartup #TargetedTherapies #CancerDrugDevelopment #BiopharmaInnovation

🚨 New episode of Biotech 2050! Host Alok Tayi, PhD sits down with Ahmed Mousa, CEO of Vicore Pharma AB, to explore his journey from biotech law to CEO, Vicore’s mission in IPF, and how AI is redefining drug discovery. 🎯 From phase 2B trials to AI-driven design 🌍 Insights on leading a Swedish-listed biotech 🧠 The future of fibrosis treatment Tune in for a thought-provoking discussion on translating science into patient impact. 🎧 Listen here 👉 https://xmrrwallet.com/cmx.plnkd.in/e3g_eCcS #Biotech2050 #DrugDevelopment #IPF #AIinBiotech #BiopharmaInnovation #FibrosisResearch #LifeSciencesLeadership #ComputationalBiology #DrugDiscovery #BiotechCEO

🚀 From scaling biologics to leading a gene therapy revolution. In this #Biotech2050 episode, host Rahul Chaturvedi talks with Curran Simpson, President & CEO of REGENXBIO, about his path from operations to CEO, the evolution of gene therapy, and building strategic partnerships to deliver life-changing treatments for MPS II, Duchenne, and Wet AMD. A must-listen for biotech leaders navigating today’s complex capital and clinical landscapes. 🎧 Tune in now! → https://xmrrwallet.com/cmx.plnkd.in/gv9HMwyg #GeneTherapy #BiotechLeadership #RareDisease #BiotechPodcast #DigitalHealth #InnovationInMedicine #RareDiseaseTreatment #DuchenneAwareness #MPSSyndrome #WetAMD #VentureBiotech #NAVPlatform

🔬 “Longevity is biotech with a purpose.” In this must-hear episode of #Biotech2050, host Alok Tayi, PhD speaks with Sergey Jakimov, Founding Partner at LongeVC, about his journey from med device founder to longevity investor — and rare disease patient. They dive into: ✅ Why aging is not a disease — but a systemic breakdown ✅ What separates hype from investable biotech ✅ How LongeVC achieved 3X returns with no write-offs ✅ The future of aging, AI, and even… pet longevity 🐾 🎧 Listen now: https://xmrrwallet.com/cmx.plnkd.in/eBS6CkWM #LongevityScience #BiotechVC #Healthspan #VentureCapital #DrugDiscovery #AgingWell #AIinBiotech

🧠 What does it take to accelerate breakthroughs in Alzheimer’s research? In this #Biotech2050 episode, host Alok Tayi, PhD speaks with Howard Fillit, MD (CSO & Co-Founder) and Mark Roithmayr (CEO) of the Alzheimer's Drug Discovery Foundation (ADDF). They discuss: ✅ The origin story of ADDF & its $100M trust 🔬 Pioneering biomarkers & blood tests for Alzheimer’s 💸 The power of venture philanthropy in de-risking drug discovery 🌍 Regulatory gaps & how nonprofits are bridging them 🧪 The future of prevention, diagnostics, and combination therapies 🎧 Listen in and be inspired by science with soul - https://xmrrwallet.com/cmx.plnkd.in/eZkdEb7r #Alzheimers #Biotech2050 #DrugDiscovery #VenturePhilanthropy #BiotechLeadership #Biomarkers #PrecisionMedicine #BiotechInnovation #Neuroscience #AgingScience #HealthcareFunding #AlzheimersResearch #BiotechPodcast

🔎 What makes a great biotech investor? In this episode of #Biotech2050, host Rahul Chaturvedi chats with Stephanie A. Sirota, Chief Business Officer & Partner at RTW Investments, LP, about building a science-led, mission-driven firm that grew from $27M to a global biotech force. 🚀 💡 Stephanie shares her personal path into biotech, the evolution of financing models, M&A trends, how RTW approaches public and private deals, and why she believes the future of medicine lies in precision, prevention, and integration. 🎧 Don’t miss this masterclass in long-game investing and impact-driven innovation. 👉 Listen now: https://xmrrwallet.com/cmx.plnkd.in/eHTmdkQP  #BiotechInvesting #LifeSciences #VentureCapital #BiotechPolicy #HealthInnovation #GLP1 #DrugDiscovery

🧬 Harnessing bold science for real patient impact. In this powerful episode of #Biotech2050, host Alok Tayi, PhD chats with Stacy Lindborg, President & CEO of IMUNON, about: ✅ Phase 3 advances in ovarian cancer using IL-12 plasmid immunotherapy 🧪 Leveraging decision sciences & trial design for breakthrough results 🎯 Building a culture of bold, mission-driven biotech leadership With a 13-month overall survival benefit and fast-track designation, Imunon is redefining what’s possible in oncology. 🎧 Listen now and get inspired: https://xmrrwallet.com/cmx.plnkd.in/eSGrbMsC #BiotechPodcast #OvarianCancer #Immunotherapy #ClinicalTrials #BiotechLeadership #AIinBiotech #LifeSciences #Podcast

🔬 What does it take to build biotech companies that thrive—even in a downturn? In this episode of #Biotech2050, 🎙️ Steve Tregay, Managing Partner at Mission BioCapital , joins host Rahul Chaturvedi to share a masterclass in early-stage biotech building. From launching Forma Therapeutics during the 2008 crash to empowering the next wave of founders through Mission BioCapital’s ⚡ Platinum Program (offering $500K + lab space!), Steve breaks down: 🧠 What first-time founders often get wrong—and how to course-correct 📈 When to evolve (or step aside) as CEO 💊 How to turn cutting-edge science into real therapeutic value 🚀 Why now is the best time to build in biotech If you're a founder, operator, or investor shaping the future of life sciences—this one's packed with insight. 👉 Listen now: https://xmrrwallet.com/cmx.plnkd.in/eyRVBBZG #Biotechpodcast #LifeSciences #BiotechFounders #PlatinumProgram #VentureCapital #BiotechStartups #Leadership #BiotechEntrepreneurship #EarlyStageBiotech #BiotechInvesting #StartupLeadership #podcast

🧠 From Army Nurse to Biotech CEO: Neil F. McFarlane’s Unconventional Path to Impact In our latest #Biotech2050 episode, host Rahul Chaturvedi sits down with Neil McFarlane, President & CEO of Zevra Therapeutics, for an unforgettable conversation. 🎯 What you'll hear: 🔹 Neil’s journey from military service to biotech boardrooms 🔹 How mission-driven leadership drives real-world innovation 🔹 Lessons from leading rare disease programs—and the regulatory hurdles that come with them 🔹 The importance of reflection, agility, and building teams that win together 🔹 Zevra’s incredible year: two product launches + pipeline progress across rare neurological and metabolic diseases Whether you’re a biotech exec, a founder, or building your leadership muscle—this episode is packed with gold. 🎧 Tune in now: https://xmrrwallet.com/cmx.plnkd.in/eUjTfDM3 #Biotech2050 #RareDisease #BiotechLeadership #DrugDevelopment #MissionDrivenLeadership #CEOInsights #LifeSciences #HealthcareInnovation #BoardLeadership

🔥 What does it take to build a game-changing biotech company? In this episode of #Biotech2050, Rajesh Devraj, President & CEO of Rectify Pharma, joins host Rahul Chaturvedi to share insights from his 30+ years in drug discovery, biotech innovation, and strategic leadership. 🔬 The science: How Rectify Pharma is pioneering small-molecule therapies for rare hepatobiliary diseases 💰 The strategy: Raising $100M+ in Series A and navigating today’s biotech funding landscape 🛠️ The execution: Building the right team, making tough calls, and driving biotech breakthroughs Raj brings a wealth of experience from big pharma to early-stage biotech, offering valuable lessons for founders, investors, and scientists alike. If you're in biotech, this is a must-listen! 🎧 Listen now: https://xmrrwallet.com/cmx.plnkd.in/ewzBBZPk #Biotech #Pharmaceuticals #DrugDiscovery #LifeSciences #HealthcareInnovation #BiotechStartup #PrecisionMedicine #BiotechInvestment #TranslationalResearch #VentureCapital #StartupLeadership #RareDiseases #Biopharma #FutureOfMedicine #BiotechFunding